Pipelines
A bio company owning antibody fragment-based technology and development innovative biologics

Target overview (CD73)

Overview (anti-CD73 IgG4)

Antibody to regulate the tumor microenvironment (TME) by inhibiting the activity of CD73
over-expressed on various cancer cells.